TTY Biopharm Co., Ltd. manufactures and markets various kinds of medicines. The company's products encompass a variety of therapeutic segments, including cardiology, gastroenterology, orthopedics and cancer.

Announcement Of Tty Biopharm'S Unaudited Income
Information In November 2024

The Company Was Invited By Yuanta Securities To
Participate The On-Line Investors' Conference

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Tty Biopharm (4105 TT)

Announcement Of Tty Biopharm'S Unaudited Income Information In November 2024

The Company Was Invited By Yuanta Securities To Participate The On-Line Investors' Conference

Announcement Of The Consolidated Financial Report For The Third Quarter Of Year 2024

Announcement Of Tty Biopharm'S Unaudited Income Information In October 2024

Announcement For The Board Of Directors Meeting Date Of The 3rd-Quarter 2024 Financial Report

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)